Sopharma AD operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other
drug stores in Europe:
Shop Apotheke Europe NV
sales of 968.06 million Euros [US$1.13 billion]
of which 84%
Farmaceutica Remedia SA
(441.48 million Romanian Leu [US$104.67 million]
Aptechnaya set' 36,6' PAO
based in RUSSIAN FEDERATION
(39.27 billion Russian Rubles [US$538.74 million]
of which 100%
During the second
quarter of 2021, sales at Sopharma AD totalled
382.65 million Bulgarian Levas.
an increase of 21.2%
from the 315.62 million Bulgarian Levas in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 765.22 million Bulgarian Levas, which is
than through the first two quarters of 2020.
During the previous 20 quarters, sales at Sopharma AD have increased compared with the same quarter in the previous year.
Sales at Sopharma AD appear to have some seasonality: during each of the previous 8
years, sales have been highest during the fourth quarter, which has accounted for
between 26.2% and 29.3%
of the annual
Sopharma AD reported sales of 1.45 billion Bulgarian Levas (US$870.99 million)
December of 2020.
increase of 12.1%
versus 2019, when the company's sales were 1.29 billion Bulgarian Levas.
This was the fourth straight year of sales growth at Sopharma AD.
Sales of Distribution of Pharmaceutical Products saw an increase
17.9% in 2020, from
1.01 billion Bulgarian Levas to 1.19 billion Bulgarian Levas.
Not all segments of Sopharma AD experienced an increase in sales in 2020:
sales of Production of Pharmaceutical Products fell 9.8% to 228.32 million Bulgarian Levas.